Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD.

Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, Albert MS, Sperling RA.

Neurology. 2005 Aug 9;65(3):404-11.

2.

Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.

Jauhiainen AM, Pihlajamäki M, Tervo S, Niskanen E, Tanila H, Hänninen T, Vanninen RL, Soininen H.

Hippocampus. 2009 Feb;19(2):166-75. doi: 10.1002/hipo.20494.

PMID:
18777563
3.

Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients.

Machulda MM, Ward HA, Borowski B, Gunter JL, Cha RH, O'Brien PC, Petersen RC, Boeve BF, Knopman D, Tang-Wai DF, Ivnik RJ, Smith GE, Tangalos EG, Jack CR Jr.

Neurology. 2003 Aug 26;61(4):500-6. Erratum in: Neurology. 2003 Oct 28;61(8):1164.

4.

Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline.

Miller SL, Fenstermacher E, Bates J, Blacker D, Sperling RA, Dickerson BC.

J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):630-5. Epub 2007 Sep 10.

5.

Semantic memory activation in amnestic mild cognitive impairment.

Woodard JL, Seidenberg M, Nielson KA, Antuono P, Guidotti L, Durgerian S, Zhang Q, Lancaster M, Hantke N, Butts A, Rao SM.

Brain. 2009 Aug;132(Pt 8):2068-78. doi: 10.1093/brain/awp157. Epub 2009 Jun 10.

6.

Medial temporal lobe function and structure in mild cognitive impairment.

Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, Dale AM, Stern CE, Blacker D, Albert MS, Sperling RA.

Ann Neurol. 2004 Jul;56(1):27-35.

7.

Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.

Bangen KJ, Restom K, Liu TT, Wierenga CE, Jak AJ, Salmon DP, Bondi MW.

J Alzheimers Dis. 2012;31 Suppl 3:S59-74.

8.

Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.

Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Bäckman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L.

Neurosci Lett. 2006 Mar 20;396(1):23-7. Epub 2006 Jan 6.

PMID:
16406347
9.

Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study.

Trivedi MA, Schmitz TW, Ries ML, Torgerson BM, Sager MA, Hermann BP, Asthana S, Johnson SC.

BMC Med. 2006 Jan 13;4:1.

10.

fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease.

Bondi MW, Houston WS, Eyler LT, Brown GG.

Neurology. 2005 Feb 8;64(3):501-8.

11.

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.

Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR Jr, Aisen PS, Thal LJ.

Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65.

PMID:
18195264
12.

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR Jr, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ; Alzheimer's Disease Cooperative Study.

Arch Neurol. 2004 Jan;61(1):59-66.

PMID:
14732621
13.

Medial temporal lobe correlates of memory screening measures in normal aging, MCI, and AD.

Sánchez-Benavides G, Gómez-Ansón B, Molinuevo JL, Blesa R, Monte GC, Buschke H, Peña-Casanova J.

J Geriatr Psychiatry Neurol. 2010 Jun;23(2):100-8. doi: 10.1177/0891988709355271. Epub 2009 Dec 22.

PMID:
20029056
14.

Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA.

J Neurosci. 2006 Oct 4;26(40):10222-31.

15.

Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.

van de Pol LA, van der Flier WM, Korf ES, Fox NC, Barkhof F, Scheltens P.

Neurology. 2007 Oct 9;69(15):1491-7.

PMID:
17923611
16.
17.

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. doi: 10.1073/pnas.1001412107. Epub 2010 May 17.

18.

Structure and function of medial temporal and posteromedial cortices in early Alzheimer's disease.

Miettinen PS, Pihlajamäki M, Jauhiainen AM, Niskanen E, Hänninen T, Vanninen R, Soininen H.

Eur J Neurosci. 2011 Jul;34(2):320-30. doi: 10.1111/j.1460-9568.2011.07745.x. Epub 2011 Jun 21.

PMID:
21692882
19.
20.

Dementia, asymmetry of temporal lobe structures, and apolipoprotein E genotype: relationships to cerebral atrophy and neuropsychological impairment.

Bigler ED, Tate DF, Miller MJ, Rice SA, Hessel CD, Earl HD, Tschanz JT, Plassman B, Welsh-Bohmer KA.

J Int Neuropsychol Soc. 2002 Nov;8(7):925-33.

PMID:
12405544

Supplemental Content

Support Center